FindTrial
Sign In

A retrospective study for comparing the predictive value of MELD, MELD-Na, and MELD-Lac for one-year survival after allograft liver transplantation

A retrospective study for comparing the predictive value of MELD, MELD-Na, and MELD-Lac for one-year survival after allograft liver transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027800
Enrollment
Unknown
Registered
2019-11-29
Start date
2019-11-13
Completion date
Unknown
Last updated
2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver transplantation

Interventions

Case series:Nil

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Allogeneic liver transplantation patients aged >=18 years.

Exclusion criteria

Exclusion criteria: 1. patients with incomplete baseline data such as gender, age, biochemical indicators, etc.; 2. patients with autologous liver transplantation; 3. lost follow-up patients; 4. Patients who suffered intraoperative cardiac arrest or died within 48 hours after surgery.

Design outcomes

Primary

MeasureTime frame
MELD;—

Countries

China

Contacts

Public ContactXiao Wang

Department of Anesthesiology, West China Hospital, Sichuan University

1490829116@qq.com+86 18980601549

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026